John Melo News Today

/PRNewswire/ -- Nalu Bio, a biotech company specializing in no-high, chemistry-derived cannabinoids to address the top health and wellness challenges, today...

/PRNewswire/ -- PIPA, the leading AI company for transforming the productivity of innovation in science, sustainability, and healthier nutrition is thrilled to...

Amyris and The Center have fared very differently on their paths.

Amyris and certain of its U.S. subsidiaries have commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware. The company said the decision was taken in order to facilitate its business and financial reorganization. Amyris intends to streamline its business portfolio to focus on its core competencies in R&D and the scale-up, commercialization, and applications development of its sustainable ingredients derived through biofermentation. The...

The company also plans to sell its consumer brands, which include JVN with Jonathan Van Ness and Rose Inc with Rosie Huntington-Whiteley.

Company lists estimated assets in the range of $500 million to $1 billion

Amyris is planning to exit its consumer brands and will begin marketing them for sale.

Amyris plans to sell consumer brands, including JVN Jonathan Van Ness, Rose Inc Rosie Huntington-Whiteley.

The news comes following the departure of John Melo, president and CEO of Amyris, who oversaw the ingredient and consumer brand companys evolution in beauty, flavor and fragrance.

Amyris CEO John Melo has departed the company, Vegamour has a new CEO and filmmaker Taika Waititi is getting in on the adaptogenics game.